期刊
CELL RESEARCH
卷 31, 期 10, 页码 1039-1040出版社
SPRINGERNATURE
DOI: 10.1038/s41422-021-00538-1
关键词
-
类别
Maraviroc, an FDA-approved therapy, may be a potentially viable treatment option for patients diagnosed with glioblastoma harboring a high amount of pericyte support cells.
Maraviroc, an FDA-approved therapy, provides a potentially viable treatment option for those diagnosed with glioblastoma harboring a high amount of pericyte support cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据